These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2. Ding Y; Yang J; Ma Y; Yao T; Chen X; Ge S; Wang L; Fan X J Exp Clin Cancer Res; 2019 Dec; 38(1):498. PubMed ID: 31856871 [TBL] [Abstract][Full Text] [Related]
19. Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implications. Corvetta D; Chayka O; Gherardi S; D'Acunto CW; Cantilena S; Valli E; Piotrowska I; Perini G; Sala A J Biol Chem; 2013 Mar; 288(12):8332-8341. PubMed ID: 23362253 [TBL] [Abstract][Full Text] [Related]
20. BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models. Wyce A; Ganji G; Smitheman KN; Chung CW; Korenchuk S; Bai Y; Barbash O; Le B; Craggs PD; McCabe MT; Kennedy-Wilson KM; Sanchez LV; Gosmini RL; Parr N; McHugh CF; Dhanak D; Prinjha RK; Auger KR; Tummino PJ PLoS One; 2013; 8(8):e72967. PubMed ID: 24009722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]